AstraZeneca’s vaccine does not protect against the South African variant of SARS-CoV-2
Will other vaccines provide long-term protection against this variant?
The AstraZeneca vaccine offers essentially zero protection against the South African variant of SARS-CoV-2, dubbed B.1.351. In contrast, the JNJ vaccine and Novavax vaccine offer some protection against B.1.351.